Source: BioPortfolio

Intellect Neurosciences: Intellect Neurosciences Inc ILNS Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300

SummaryIntellect Neurosciences Inc Intellect Neuro is a biotechnology company that discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and other serious neurological disorders. The company's internal drug dis...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Elliot M. Maza's photo - Chairman & CEO of Intellect Neurosciences

Chairman & CEO

Elliot M. Maza

CEO Approval Rating

68/100

Read more